Importer of Controlled Substances Application: Andersonbrecon, Inc, DBA PCI of Illinois, 23064 [2020-08669]
Download as PDF
<![CDATA[
23064
Federal Register / Vol. 85, No. 80 / Friday, April 24, 2020 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—IMS Global Learning
Consortium, Inc.
khammond on DSKJM1Z7X2PROD with NOTICES
Notice is hereby given that, on April
14, 2020, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), IMS Global Learning
Consortium, Inc. (‘‘IMS Global’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 42 Lines, Champaign, IL;
Chan Zuckerberg Initiative, LLC,
Redwood City, CA; E-Locker, Norman,
OK; Idaho Division of Career Technical
Educ., Boise, ID; IQ4, Woodcliff, NJ;
Ladok/Umea˚ University, Stockholm,
SWEDEN; Michigan Virtual University,
Lansing, MI; NDLA, Bergen, NORWAY;
North Carolina State University c/o The
Friday Institute for Educational
Innovation, Raleigh, NC; Paradigm, Inc.,
Virginia Beach, VA; Partners4 Results,
Waukesha, WI; RethinkED, New York,
NY; Suitable, Philadelphia, PA; UVII,
New York, NY; and Pearson K12
Learning, Chandler, AZ, have been
added as parties to this venture.
Also, Learning Logistics, McKinney,
TX; Questar Assessment Inc., Apple
Valley, MN; Follett Corporation,
Westchester, IL; and Aspire/Ability Inc.,
Payson, UT, have withdrawn as parties
to this venture.
In addition, Academic Center for
Computing and Media Studies, Kyoto
University has changed its name to
Institute for Information Management
and Communications, Kyoto University,
Kyoto, JAPAN; University of Maryland
University College to University of
Maryland Global Campus, Adelphi, MD;
and Learning Machine to Hyland
Credentials, Dallas, TX.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open and IMS Global
intends to file additional written
notifications disclosing all changes in
membership.
On April 7, 2000, IMS Global filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on September 13, 2000 (65 FR
55283).
The last notification was filed with
the Department on January 28, 2020. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on February 10, 2020 (85 FR 7605).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2020–08672 Filed 4–23–20; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–632]
Importer of Controlled Substances
Application: Andersonbrecon, Inc,
DBA PCI of Illinois
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 26, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 26, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on March 31, 2020,
Andersonbrecon, Inc, DBA PCI of
Illinois, 4545 Assembly Drive, Rockford,
Illinois 61109, applied to be registered
as an importer of the following basic
class(es) of controlled substances:
DATES:
Controlled substance
Drug code
Schedule
Tetrahydrocannabinols ....................................................................................................................................................
7370
I
The company plans to import the
listed controlled substance for clinical
trials only. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
approved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
Federal Bureau of Investigation
[OMB Number 1110–0052]
[FR Doc. 2020–08669 Filed 4–23–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection;
Applicant Information Form (1–783)
Criminal Justice Information
Services Division, Federal Bureau of
Investigation, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
VerDate Sep<11>2014
17:03 Apr 23, 2020
Jkt 250001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
E:\FR\FM\24APN1.SGM
24APN1
]]>Agencies
[Federal Register Volume 85, Number 80 (Friday, April 24, 2020)]
[Notices]
[Page 23064]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08669]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-632]
Importer of Controlled Substances Application: Andersonbrecon,
Inc, DBA PCI of Illinois
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 26, 2020.
Such persons may also file a written request for a hearing on the
application on or before May 26, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 31, 2020, Andersonbrecon, Inc, DBA PCI of
Illinois, 4545 Assembly Drive, Rockford, Illinois 61109, applied to be
registered as an importer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................... 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substance for
clinical trials only. Approval of permit applications will occur only
when the registrant's business activity is consistent with what is
authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the import of Food and Drug
Administration-approved or non-approved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08669 Filed 4-23-20; 8:45 am]
BILLING CODE 4410-09-P
